Lancets Market by Type (Safety Lancets (Push button, Pressure Activated, Side Button), Personal Lancets), Application (Glucose Testing, Hemoglobin Testing), End User (Hospital, Clinic, Homecare), Region - Global Forecasts to 2024
The lancets market size is projected to reach USD 1,442 million by 2024, at a CAGR of 12.4%. Growth in the lancets market is mainly driven by the growing prevalence of diabetes and the high prevalence of infectious diseases across the globe. In addition, emerging markets such as India and China are expected to offer growth opportunities for players operating in the lancets market during the forecast period. However, the risk of needlestick injuries, the reuse of lancets, and the poor reimbursement scenario in developing countries are restricting the growth of this market.
The hospitals and clinics segment to dominate the lancets market in 2019
By end user, the lancets market is segmented into hospitals and clinics, home care settings, and other end users (diagnostic centers and pathology laboratories). In 2019, the hospitals and clinics segment is expected to dominate the lancets market. The dominant share of this segment is primarily attributed to the availability of a large patient pool and the increasing prevalence of infectious diseases that require blood testing for diagnosis and treatment.
The APAC market is expected to grow at the highest CAGR during the forecast period
North America is projected to dominate the lancets market in 2019. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period. The growing healthcare industry, rising geriatric population in China and India, rapid economic growth, and rising awareness about diabetes treatment are some of the key factors driving the growth of the lancets market in the Asia Pacific region.
Key Market Players
Prominent players in the lancets market are Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt (Germany), and SteriLance Medical (Suzhou) (China).
Roche Diagnostics (Switzerland) is the diagnostics division of F. Hoffmann-La Roche AG. The company develops and manufactures equipment and reagents used for research and medical diagnostic applications. Roche operates through four business segments, namely, Centralized and Point of Care Solutions, Diabetes Care, Molecular Diagnostics, and Tissue Diagnostics. The company offers lancets to various end users including physicians, hospitals, clinics, academic institutes, and for personal use through its Diabetes Care segment.
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
:
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
20172024 |
|
Base year considered |
2018 |
|
Forecast period |
20192024 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Type, Application, End User, and Region |
|
Geographies covered |
North America, Europe, Asia Pacific, and the Rest of the World |
|
Companies covered |
Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt (Germany), and SteriLance Medical (Suzhou) (China). |
The research report categorizes the market into the following segments and subsegments:
Lancets Market, by Type
- Safety Lancets
- Personal Lancets
Lancets Market, by Application
- Glucose Testing
- Hemoglobin Testing
- Coagulation Testing
- Other Applications
Lancets Market, by Region
- North America
- Europe
- Asia Pacific
- China
- Australia
- South Korea
- Indonesia
- Malaysia
- Thailand
- Vietnam
- Singapore
- New Zealand
- Rest of Asia Pacific
- Rest of the World
Recent Developments
- In 2018, HTL-STREFA expanded its storage capacity in Leczyca by almost 50%, with an equivalent of 3,550 m2 additional storage space.
- In 2018, HTL-STREFA was acquired by Investindustrial. This acquisition helped the companies partner for diabetes management, thus serving an extensive customer base.
- In 2017, Owen Mumford opened its new facility in Malaysia to strengthen and accelerate the growth of the company in the Asia Pacific region.
Critical questions answered in the report:
- Which regions are likely to grow at the highest CAGR?
- What are the recent trends affecting the lancets market?
- Who are the key players in the market and how intense is the competition?
- What are the application areas of lancets?
- What are the challenges hindering the adoption of lancets?
Frequently Asked Questions (FAQ):
Which is the leading type of lancets?
On the basis of type, the lancets market is segmented into safety lancets, and personal lancets. The safety lancets segment is expected to hold the largest share the lancets market in 2019 and is also projected to record the highest CAGR during the forecast period. The large share of this segment can primarily be attributed to the advantages associated with safety lancets such as easy to use; prevents needle stick injuries and cross contamination; and painless vein puncture.
Which is the leading application of lancets?
On the basis of application, the lancets market has been segmented into glucose testing, hemoglobin testing, coagulation testing, and other applications. The glucose testing segment is expected to hold the largest share of the lancets market in 2019 and is projected to record the highest CAGR during the forecast period. The increasing prevalence of diabetes propelling the growth of this market segment.
Which is the leading end user of lancets?
On the basis of end user, the lancets market is segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment is expected to hold the share of the lancets market in 2019. This is attributed to the raising awareness about diabetes treatment and increasing prevalence of infectious diseases that require blood testing.
Which are the key players operating in lancets Market?
The global lancets market is highly competitive, owing to the presence of several large and small players. Becton, Dickinson And Company (US), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt (Germany), and SteriLance Medical (Suzhou) (China).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 12)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 15)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Market Data Validation and Triangulation
2.3 Assumptions for the Study
3 Executive Summary (Page No. - 24)
4 Premium Insights (Page No. - 28)
4.1 Lancets Market Overview
4.2 North America: Lancets Market, By Type, 2018
4.3 Europe: Lancets Market, By Type, 2018
4.4 Lancets Market: Geographic Snapshot
5 Market Overview (Page No. - 32)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Prevalence of Diabetes
5.2.1.2 High Prevalence of Infectious Diseases
5.2.2 Restraints
5.2.2.1 Risk of Needlestick Injuries
5.2.2.2 Poor Reimbursement Scenario in Developing Countries
5.2.3 Opportunities
5.2.3.1 High Growth Prospects in Emerging Countries
5.2.4 Challenges
5.2.4.1 Reuse of Lancets
6 Lancets Market, By Type (Page No. - 36)
6.1 Introduction
6.2 Safety Lancets
6.2.1 Push-Button Lancets
6.2.1.1 Ease of Use and Simplicity have Driven Demand for Push-Button Lancets
6.2.2 Pressure-Activated Lancets
6.2.2.1 These Lancets are Available in A Number of Gauge Sizes and Penetration Depths
6.2.3 Side-Button Lancets
6.2.3.1 Ease of Use and Anti-Reuse Measures have Made Side-Button Lancets Popular Among End Users
6.3 Personal Lancets
6.3.1 Increasing Prevalence of Diabetes has Resulted in Significant Demand for Personal Lancets
7 Lancets Market, By Application (Page No. - 42)
7.1 Introduction
7.2 Glucose Testing
7.2.1 Increasing Diabetes Prevalence is Expected to Drive the Demand for Lancets in Glucose Testing During the Forecast Period
7.3 Hemoglobin Testing
7.3.1 High Prevalence of Anemia Expected to Increase Hemoglobin Testing Volume and the Demand for Lancets
7.4 Coagulation Testing
7.4.1 Rising Prevalence of Liver Diseases, Thrombophilia, and Hemophilia to Drive the Demand for Coagulation Testing
7.5 Other Applications
7.5.1 This Segment Covers Other Applications of Lancets, Such as Pregnancy Testing, Infectious Diseases Testing, and Cholesterol Testing.
8 Lancets Market, By End User (Page No. - 48)
8.1 Introduction
8.2 Hospitals & Clinics
8.2.1 Increasing Incidence of Diseases That Require Blood Testing for Diagnosis and Treatment is Driving the Adoption of Lancets in Hospitals and Clinics
8.3 Home Care Settings
8.3.1 Increasing Prevalence of Diabetes is Expected to Drive the Demand for Lancets in the Home Care Settings Segment During the Forecast Period
8.4 Other End Users
9 Lancets Market, By Region (Page No. - 53)
9.1 Introduction
9.2 North America
9.2.1 High Diabetic Population and Reimbursement Coverage for Lancets Will Drive Market Growth in North America
9.3 Europe
9.3.1 Rising Awareness on Diabetes Treatment and Prevention Will Contribute to Lancet Use in Europe
9.4 Asia Pacific
9.4.1 Rapid Economic Growth in APAC Countries Will Provide Opportunities for Market Players
9.5 RoW
10 Competitive Landscape (Page No. - 79)
10.1 Overview
10.2 Competitive Leadership Mapping (2018)
10.2.1 Vendor Inclusion Criteria
10.2.2 Visionary Leaders
10.2.3 Innovators
10.2.4 Dynamic Differentiators
10.2.5 Emerging Companies
11 Company Profiles (Page No. - 81)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 Becton, Dickinson and Company
11.2 Roche Diagnostics
11.3 Ypsomed
11.4 B. Braun Melsungen
11.5 Terumo Corporation
11.6 Owen Mumford
11.7 HTL-Strefa S.A
11.8 Arkray
11.9 Sarstedt
11.10 Sterilance Medical (Suzhou)
11.11 Medline Industries
11.12 Intrinsyk
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. - 99)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details
List of Tables (75 Tables)
Table 1 Incidence of Infectious Diseases
Table 2 Lancets Market, By Type, 20172024 (USD Billion)
Table 3 Safety Lancets: Market, By Region, 20172024 (USD Million)
Table 4 Safety Lancets: Market, By Type, 20172024 (USD Million)
Table 5 Push-Button Lancets: Market, By Region, 20172024 (USD Million)
Table 6 Pressure-Activated Lancets: Market, By Region, 20172024 (USD Million)
Table 7 Side-Button Lancets: Market, By Region, 20172024 (USD Million)
Table 8 Personal Lancets: Market, By Region, 20172024 (USD Million)
Table 9 Market, By Application, 20172024 (USD Million)
Table 10 Market for Glucose Testing, By Region, 20172024 (USD Million)
Table 11 Market for Hemoglobin Testing, By Region, 20172024 (USD Million)
Table 12 Market for Coagulation Testing, By Region, 20172024 (USD Million)
Table 13 Market for Other Applications, By Region, 20172024 (USD Million)
Table 14 Market, By End User, 20172024 (USD Million)
Table 15 Market for Hospitals & Clinics, By Region, 20172024 (USD Million)
Table 16 Market for Home Care Settings, By Region, 20172024 (USD Million)
Table 17 Market for Other End Users, By Region, 20172024 (USD Million)
Table 18 Market, By Region, 20172024 (USD Million)
Table 19 North America: Market, By Type, 20172024 (USD Million)
Table 20 North America: Safety Lancets: Market, By Type, 20172024 (USD Million)
Table 21 North America: Market, By Application, 20172024 (USD Million)
Table 22 North America: Market, By End User, 20172024 (USD Million)
Table 23 Europe: Market, By Type, 20172024 (USD Million)
Table 24 Europe: Safety Lancets Market, By Type, 20172024 (USD Million)
Table 25 Europe: Market, By Application, 20172024 (USD Million)
Table 26 Europe: Market, By End User, 20172024 (USD Million)
Table 27 APAC: Market, By Country, 20172024 (USD Million)
Table 28 APAC: Market, By Type, 20172024 (USD Million)
Table 29 APAC: Safety Lancets Market, By Type, 20172024 (USD Million)
Table 30 APAC: Market, By Application, 20172024 (USD Million)
Table 31 APAC: Market, By End User, 20172024 (USD Million)
Table 32 China: Market, By Type, 20172024 (USD Million)
Table 33 China: Safety Lancets Market, By Type, 20172024 (USD Million)
Table 34 China: Market, By Application, 20172024 (USD Million)
Table 35 China: Market, By End User, 20172024 (USD Million)
Table 36 Australia: Market, By Type, 20172024 (USD Million)
Table 37 Australia: Safety Lancets Market, By Type, 20172024 (USD Million)
Table 38 Australia: Market, By Application, 20172024 (USD Million)
Table 39 Australia: Market, By End User, 20172024 (USD Million)
Table 40 South Korea: Market, By Type, 20172024 (USD Million)
Table 41 South Korea: Safety Lancets Market, By Type, 20172024 (USD Thousand)
Table 42 South Korea: Market, By Application, 20172024 (USD Thousand)
Table 43 South Korea: Market, By End User, 20172024 (USD Million)
Table 44 Indonesia: Market, By Type, 20172024 (USD Million)
Table 45 Indonesia: Safety Lancets Market, By Type, 20172024 (USD Thousand)
Table 46 Indonesia: Market, By Application, 20172024 (USD Thousand)
Table 47 Indonesia: Market, By End User, 20172024 (USD Million)
Table 48 Malaysia: Market, By Type, 20172024 (USD Million)
Table 49 Malaysia: Safety Lancets Market, By Type, 20172024 (USD Thousand)
Table 50 Malaysia: Market, By Application, 20172024 (USD Thousand)
Table 51 Malaysia: Market, By End User, 20172024 (USD Million)
Table 52 Thailand: Market, By Type, 20172024 (USD Million)
Table 53 Thailand: Safety Lancets Market, By Type, 20172024 (USD Thousand)
Table 54 Thailand: Market, By Application, 20172024 (USD Thousand)
Table 55 Thailand: Market, By End User, 20172024 (USD Thousand)
Table 56 Vietnam: Market, By Type, 20172024 (USD Thousand)
Table 57 Vietnam: Safety Lancets Market, By Type, 20172024 (USD Thousand)
Table 58 Vietnam: Market, By Application, 20172024 (USD Thousand)
Table 59 Vietnam: Market, By End User, 20172024 (USD Thousand)
Table 60 Singapore: Market, By Type, 20172024 (USD Thousand)
Table 61 Singapore: Safety Lancets Market, By Type, 20172024 (USD Thousand)
Table 62 Singapore: Market, By Application, 20172024 (USD Thousand)
Table 63 Singapore: Market, By End User, 20172024 (USD Thousand)
Table 64 New Zealand: Market, By Type, 20172024 (USD Thousand)
Table 65 New Zealand: Safety Lancets Market, By Type, 20172024 (USD Thousand)
Table 66 New Zealand: Market, By Application, 20172024 (USD Thousand)
Table 67 New Zealand: Market, By End User, 20172024 (USD Thousand)
Table 68 RoAPAC: Market, By Type, 20172024 (USD Million)
Table 69 RoAPAC: Safety Lancets Market, By Type, 20172024 (USD Million)
Table 70 RoAPAC: Market, By Application, 20172024 (USD Million)
Table 71 RoAPAC: Market, By End User, 20172024 (USD Million)
Table 72 RoW: Market, By Type, 20172024 (USD Million)
Table 73 RoW: Safety Lancets Market, By Type, 20172024 (USD Million)
Table 74 RoW: Market, By Application, 20172024 (USD Million)
Table 75 RoW: Market, By End User, 20172024 (USD Million)
List of Figures (27 Figures)
Figure 1 Lancets Market
Figure 2 Lancets Market: Research Methodology
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Lancets: Market, By Type, 20192024
Figure 9 Lancets: Market, By Application, 2019
Figure 10 Lancets: Market, By End User, 2018 vs 2023 (USD Million)
Figure 11 Geographical Snapshot of the Lancets Market
Figure 12 Increasing Incidence Diabetes to Drive the Growth of the Lancets Market
Figure 13 Safety Lancets Held Largest Share of the North American Market, 2018
Figure 14 Push-Button Lancets to Dominate the European Market During the Forecast Period
Figure 15 Asia Pacific to Grow at the Highest CAGR During the Forecast Period
Figure 16 Lancets Market: Drivers, Restraints, Opportunities, & Challenges
Figure 17 Safety Lancets to Witness the Highest Growth in the Lancets Market From 2019 to 2024
Figure 18 Glucose Testing Was the Largest Application Segment in the Lancets Market in 2018
Figure 19 Lancets Market, By End User, 2019 vs 2024 (USD Million)
Figure 20 North America: Lancets Market Snapshot
Figure 21 Asia Pacific: Lancets Market Snapshot
Figure 22 MnM Dive-Vendor Comparison Matrix: Lancets Market
Figure 23 Becton, Dickinson and Company: Company Snapshot
Figure 24 Roche Diagnostics: Company Snapshot
Figure 25 Ypsomed: Company Snapshot
Figure 26 B.Braun: Company Snapshot
Figure 27 Terumo Corporation: Company Snapshot
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the lancets market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the lancets market. The primary sources from the demand side included industry experts, such as researchers and scientists, and industry experts from medical devices companies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by type, application, end user, and region).
Data Triangulation
After arriving at the market size, the lancets market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments.
Objectives of the Study
- To define, describe, segment, and forecast the global lancets market by type, application, end user, and region
- To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the lancets market in four main regions along with their respective key countries (North America, Europe, Asia Pacific, and the Rest of the World)
- To profile key players in the global lancets market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as expansions and collaborations of the leading players in the lancets market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Geographic Analysis
- A further breakdown of the North American lancets market into the US and Canada
- A further breakdown of the European lancets market into Germany, the UK, France, and the Rest of Europe
Growth opportunities and latent adjacency in Lancets Market